Clinical Trial Update: Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial investigating thalidomide for chemotherapy-related nausea and vomiting in pancreatic cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Pancreatic Cancer

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Cancer Stage IV, Chemotherapy-induced Nausea and Vomiting | Phase 3 | Status: RECRUITING